Trademark: 90558538
Word
PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE
Status
Registered
Status Code
700
Status Date
Tuesday, July 26, 2022
Serial Number
90558538
Registration Number
6800412
Registration Date
Tuesday, July 26, 2022
Mark Type
4000
Filing Date
Wednesday, March 3, 2021
Published for Opposition
Tuesday, May 10, 2022

Trademark Owner History
Precision Medicine Group, LLC - Original Registrant

Classifications
41 Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
35 Business management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business consulting services provided to the healthcare industry in the nature of the creation, collection, analysis, and reporting of data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition
42 Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition
"CELL & GENE THERAPY COLLECTIVE"

Trademark Events
Jul 26, 2022
Notice Of Registration Confirmation Emailed
Jul 26, 2022
Registered-Principal Register
May 10, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Published For Opposition
Apr 20, 2022
Notification Of Notice Of Publication E-Mailed
Apr 4, 2022
Law Office Publication Review Completed
Apr 1, 2022
Approved For Pub - Principal Register
Jul 29, 2021
Combined Examiner's Amendment/Priority Action Entered
Jul 29, 2021
Assigned To Lie
Jul 26, 2021
Teas Response To Office Action Received
Jul 22, 2021
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jul 22, 2021
Examiner's Amendment/Priority Action E-Mailed
Jul 22, 2021
Combined Examiner's Amendment/Priority Action Automatic Entry
Jul 22, 2021
Examiners Amendment And/Or Priority Action - Completed
Jul 21, 2021
Assigned To Examiner
Jun 2, 2021
New Application Office Supplied Data Entered In Tram
Mar 6, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24